3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
34
UNKNOWN
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia
1
Interventions
toripalimab
1
pegylated granulocyte colony-stimulating factor
1
Pemetrexed
1
Idarubicin
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Growth Hormone
1
Cytarabine
1
Cisplatin
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
UNKNOWN
×
Cytarabine
×
Clear all
NCT01191541
2021-08-10
Ara-C
ChineseAMS
Phase 4
Completed
65 enrolled
8 charts